drugset / Trial / NCT00218283
Nicotine Lozenge to Reduce Smokeless Tobacco Use
Phase 2
Completed
100 enrolled
National Institute on Drug Abuse (NIDA)
University of Minnesota · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Smokeless tobacco (ST), which includes both chewing tobacco and snuff, has as many health risks associated with its use as cigarettes. While there are many treatment programs that focus on stopping tobacco use, there are no interventions that specifically focus on reducing tobacco use. This study will evaluate the effectiveness of nicotine lozenge at reducing tobacco use in ST users.
Timeline
- Start
- 2005-01
- Primary completion
- 2007-06
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nicotine | Unknown | — | Oral |